RXL
ProShares Ultra Health Care [RXL] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
RXL Stock Summary
Top RXL Correlated Resources
RXL
Top 10 Correlated ETFs
RXL
Top 10 Correlated Stocks
RXL
In the News
RXL Financial details
Company Rating
-
Market Cap
93.31M
Income
-
Revenue
-
Book val./share
-
Cash/share
-
Dividend
0.17
Dividend %
0.17%
Employees
-
Optionable
No
Shortable
Yes
Earnings
-
P/E
0
Forward P/E
-
PEG
-
P/S
-
P/B
-
P/C
-
P/FCF
-
Quick Ratio
-
Current Ratio
-
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-
EPS next Y
-
EPS next Q
-
EPS this Y
-
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-
EPS Q/Q
-
-
-
-
-
SMA20
-14.04%
SMA50
-15.79%
SMA100
-12.87%
Inst Own
-
Inst Trans
-
ROA
-
ROE
-
ROC
-
Gross Margin
-
Oper. Margin
-
Profit Margin
-
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
74.44-106.54
52W High
-62.33%
52W Low
-46.03%
RSI
33.3
Rel Volume
2.61
Avg Volume
2.94K
Volume
7.66K
Perf Week
-9.38%
Perf Month
-22.06%
Perf Quarter
-23.98%
Perf Half Y
-25.7%
-
-
-
-
Beta
1.35
-
-
Volatility
1.14%, 3.36%
Prev Close
-4.14%
Price
39.9355
Change
-4.85%
RXL Financial Performance
RXL Frequently Asked Questions
What is ProShares Ultra Health Care stock symbol ?
ProShares Ultra Health Care is a US stock and trading under the symbol RXL
What is ProShares Ultra Health Care stock quote today ?
ProShares Ultra Health Care stock price is $39.9355 today.
Is ProShares Ultra Health Care stock public?
Yes, ProShares Ultra Health Care is a publicly traded company.
Company Profile
- Volume Average 2.94K
- Market Capitalization 93.31M
- Headquarters US
- IPO Date 2007-02-01
The fund invests in financial instruments that ProShare Advisors believes, in combination, should produce daily returns consistent with the fund's investment objective. The index is designed to measure the stock performance of U.S. companies in the healthcare industry. Component companies include, among others, health care providers, biotechnology companies, medical supplies, advanced medical devices and pharmaceuticals. The fund is non-diversified.
